Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Angewandte Chemie (International Ed. in English)|September 7, 2016
Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide ReceptorsYing Wang, Jintang Du, Huafei Zou, et al.
ACS Chemical Biology|October 6, 2016
Rational Design of Dual Agonist-Antibody Fusions as Long-acting Therapeutic HormonesYan Liu, Ying Wang, Yong Zhang, et al.
Acta Pharmaceutica Sinica. B|January 13, 2022
A small molecule UPR modulator for diabetes identified by high throughput screeningValeria Marrocco, Tuan Tran, Siying Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 28, 2011
Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activityLaura H Jacobson, S Renee Commerford, Sarah P Gerber, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2024
Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repairSida Shao, Nan Zhang, Gregory P Specht, et al.
Nature Communications|November 3, 2019
Neratinib protects pancreatic beta cells in diabetesAmin Ardestani, Sijia Li, Karthika Annamalai, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2007
The Guinea pig as a preclinical model for demonstrating the efficacy and safety of statinsCort S Madsen, Evan Janovitz, Rongan Zhang, et al.
PNAS Nexus|March 26, 2024
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitisRyan Watkins, Ana Gamo, Seung Hyuk Choi, et al.
Nature Communications|October 27, 2015
Inhibition of DYRK1A and GSK3B induces human β-cell proliferationWeijun Shen, Brandon Taylor, Qihui Jin, et al.
Journal of Medicinal Chemistry|April 17, 2008
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potentialSaleem Ahmad, Cort S Madsen, Philip D Stein, et al.
Pageof 2